171 related articles for article (PubMed ID: 1634535)
1. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
2. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. II. Properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14974-81. PubMed ID: 1634536
[TBL] [Abstract][Full Text] [Related]
3. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
5. Biotin derivatives of D-Phe-Pro-Arg-CH2Cl for active-site-specific labeling of thrombin and other serine proteinases.
Anderson PJ; Bock PE
Anal Biochem; 2001 Sep; 296(2):254-61. PubMed ID: 11554721
[TBL] [Abstract][Full Text] [Related]
6. Analogs of human plasminogen that are labeled with fluorescence probes at the catalytic site of the zymogen. Preparation, characterization, and interaction with streptokinase.
Bock PE; Day DE; Verhamme IM; Bernardo MM; Olson ST; Shore JD
J Biol Chem; 1996 Jan; 271(2):1072-80. PubMed ID: 8557633
[TBL] [Abstract][Full Text] [Related]
7. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
8. Evidence that meizothrombin is an intermediate product in the clotting of whole blood.
Bovill EG; Tracy RP; Hayes TE; Jenny RJ; Bhushan FH; Mann KG
Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):754-8. PubMed ID: 7773729
[TBL] [Abstract][Full Text] [Related]
9. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
10. Zymogen/enzyme discrimination using peptide chloromethyl ketones.
Williams EB; Krishnaswamy S; Mann KG
J Biol Chem; 1989 May; 264(13):7536-45. PubMed ID: 2708377
[TBL] [Abstract][Full Text] [Related]
11. Thioester peptide chloromethyl ketones: reagents for active site-selective labeling of serine proteinases with spectroscopic probes.
Bock PE
Methods Enzymol; 1993; 222():478-503. PubMed ID: 8412811
[No Abstract] [Full Text] [Related]
12. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.
Harmon JT; Jamieson GA
J Biol Chem; 1986 Dec; 261(34):15928-33. PubMed ID: 3023333
[TBL] [Abstract][Full Text] [Related]
13. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation.
Rosing J; Zwaal RF; Tans G
J Biol Chem; 1986 Mar; 261(9):4224-8. PubMed ID: 3753979
[TBL] [Abstract][Full Text] [Related]
14. New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK.
Martin PD; Malkowski MG; Box J; Esmon CT; Edwards BF
Structure; 1997 Dec; 5(12):1681-93. PubMed ID: 9438869
[TBL] [Abstract][Full Text] [Related]
15. Progressive development of a thrombin inhibitor binding site.
Hibbard LS; Nesheim ME; Mann KG
Biochemistry; 1982 May; 21(10):2285-92. PubMed ID: 6896460
[TBL] [Abstract][Full Text] [Related]
16. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
[TBL] [Abstract][Full Text] [Related]
17. The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution.
Martin PD; Robertson W; Turk D; Huber R; Bode W; Edwards BF
J Biol Chem; 1992 Apr; 267(11):7911-20. PubMed ID: 1560020
[TBL] [Abstract][Full Text] [Related]
18. Role of thrombin exosites in inhibition by heparin cofactor II.
Rogers SJ; Pratt CW; Whinna HC; Church FC
J Biol Chem; 1992 Feb; 267(6):3613-7. PubMed ID: 1740413
[TBL] [Abstract][Full Text] [Related]
19. Crystallographic determination of the structures of human alpha-thrombin complexed with BMS-186282 and BMS-189090.
Malley MF; Tabernero L; Chang CY; Ohringer SL; Roberts DG; Das J; Sack JS
Protein Sci; 1996 Feb; 5(2):221-8. PubMed ID: 8745399
[TBL] [Abstract][Full Text] [Related]
20. Structure and behavior of human α-thrombin upon ligand recognition: thermodynamic and molecular dynamics studies.
Silva Vde A; Cargnelutti MT; Giesel GM; Palmieri LC; Monteiro RQ; Verli H; Lima LM
PLoS One; 2011; 6(9):e24735. PubMed ID: 21935446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
